Triamcinolone Reduces Neovascularization, Capillary Density and IGF-1 Receptor Phosphorylation in a Model of Oxygen-Induced Retinopathy
Author(s) -
M. Elizabeth Hartnett,
David Martiniuk,
Yuta Saito,
Pete Geisen,
Lynda J. Peterson,
Janet R. McColm
Publication year - 2006
Publication title -
investigative ophthalmology and visual science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.935
H-Index - 218
eISSN - 1552-5783
pISSN - 0146-0404
DOI - 10.1167/iovs.06-0450
Subject(s) - triamcinolone acetonide , retinal , trypan blue , neovascularization , retina , vascular endothelial growth factor , endocrinology , medicine , in vivo , retinopathy , ophthalmology , apoptosis , chemistry , angiogenesis , biology , biochemistry , diabetes mellitus , vegf receptors , microbiology and biotechnology , neuroscience
To study the effects of intravitreous triamcinolone acetonide (TA) on neovascularization (NV), capillary density, and retinal endothelial cell (REC) viability in a model of oxygen-induced retinopathy (OIR).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom